None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subjects whose age of 20 years or more and less than 55 years 2) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntary participate in the study and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects having serious hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders 2) Subjects who have a seasonal allergic rhinitis (cedar or Japanese cypress pollen) with moderate or severe symptoms 3) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 4) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 5) Subjects deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of water absorption | — |
Secondary
| Measure | Time frame |
|---|---|
| Water retention, Changes of blood glucose | — |
Countries
Japan
Contacts
Soiken Inc. Representative Director